| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
London Center of Pediatric Endocrinology and Metabolism and Institute of Child Health, London, United Kingdom WC1N 1EH
Address all correspondence and requests for reprints to: Dr. Mehul Dattani, Pediatric Endocrinology, Institute of Child Health and Great Ormond Street Childrens Hospital, 30 Guilford Street, London, United Kingdom WC1N 1EH. E-mail: mdattani{at}ich.ucl.ac.uk.
To determine the value of the TRH test, we analyzed the unstimulated serum T4 and TSH concentrations in 54 children with central hypothyroidism. A TRH test was performed in 30 patients. Midline brain defects (septo-optic dysplasia, 28; holoprosencephaly, 2) and combined pituitary hormone deficiencies were present in 30 and 52 patients, respectively. The mean serum free T4, total T4, and basal TSH concentrations were 0.6 ng/dl, 4.0 µg/dl, and 2.8 µU/ml, respectively. Five patients demonstrated elevated basal serum TSH concentrations. A normal TRH test [increase (
) in TSH, 4.517.8], based on data from 30 controls, was documented in 23.3% of patients. Brisk (
TSH, >17.8), absent/blunted (
TSH, <4.5), and delayed responses were documented in 16.7%, 30%, and 30% of patients, respectively. The mean age at diagnosis was 2.8 yr, with 8 patients evolving into TSH deficiency. It was not possible to differentiate patients as having pituitary or hypothalamic disease based solely on the TRH test results. Patients with septo-optic dysplasia were diagnosed earlier and had elevated basal serum TSH and PRL concentrations, diabetes insipidus, and evolving disease. Although full pituitary function assessment is mandatory to identify combined pituitary hormone deficiencies, a TRH test is not essential, and the diagnosis should be made by serial T4 measurements.
This work was supported by Medical Research Council Career Establishment Grants (to M.T.D. and A.M.) and a grant from Novo Nordisk, United Kingdom (to A.M.).
Abbreviations: CH, Central hypothyroidism; CPHD, combined pituitary hormone deficiencies; FT4, free T4; GN, gonadotropin; H-P, hypothalamo-pituitary; HPE, holoprosencephaly; M/F, male/female ratio; MRI, magnetic resonance imaging;
TSH, increase in TSH; SOD, septo-optic dysplasia; TT4, total T4.
This article has been cited by other articles:
![]() |
D. A. van Tijn, J. J. M. de Vijlder, and T. Vulsma Role of the Thyrotropin-Releasing Hormone Stimulation Test in Diagnosis of Congenital Central Hypothyroidism in Infants J. Clin. Endocrinol. Metab., February 1, 2008; 93(2): 410 - 419. [Abstract] [Full Text] [PDF] |
||||
![]() |
American Academy of Pediatrics, S. R. Rose, and the Section on Endocrinology and Committee on, American Thyroid Association, R. S. Brown, and the Public Health Committee, and Lawson Wilkins Pediatric Endocrine Society Update of newborn screening and therapy for congenital hypothyroidism. Pediatrics, June 1, 2006; 117(6): 2290 - 2303. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. van Tijn, J. J. M. de Vijlder, B. Verbeeten Jr., P. H. Verkerk, and T. Vulsma Neonatal Detection of Congenital Hypothyroidism of Central Origin J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3350 - 3359. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |